# The Study of Immunization in People Living With HIV Undergoing an ATI for Elicitation of VRC01-lineage Antibodies

> **NCT06006546** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 35 (actual)

## Conditions studied

- Chronic HIV Infection

## Interventions

- **BIOLOGICAL:** 426c.Mod.Core-C4b
- **OTHER:** Adjuvant 3M-052-AF+Alum

## Key facts

- **NCT ID:** NCT06006546
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-01-03
- **Primary completion:** 2026-10-27
- **Final completion:** 2026-10-27
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2026-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06006546

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06006546, "The Study of Immunization in People Living With HIV Undergoing an ATI for Elicitation of VRC01-lineage Antibodies". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT06006546. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*